Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial

INTRODUCTION: Consideration of treatment-related quality of life (QOL) is important in diabetes management. However, no studies have compared the influence of dipeptidyl peptidase-4 inhibitors versus metformin on treatment-related QOL when used as first-line therapy in patients with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Mita, Tomoya, Hiyoshi, Toru, Yoshii, Hidenori, Chimori, Hiroko, Ikeda, Kazuo, Sato, Junko, Watada, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984940/
https://www.ncbi.nlm.nih.gov/pubmed/29744822
http://dx.doi.org/10.1007/s13300-018-0437-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984940/
https://www.ncbi.nlm.nih.gov/pubmed/29744822
http://dx.doi.org/10.1007/s13300-018-0437-x

Ejemplares similares